Dr. Hussein Mohamed Ibrahim

Dr. Hussein Mohamed Ibrahim Aqoonteena waa dhakhtarka Bari

01/12/2025
01/11/2025
27/10/2025
22/10/2025

Appendicitis
(based on The 5-Minute Clinical Consult 2023)

👉Definition

Acute appendicitis is inflammation of the vermiform appendix, usually caused by luminal obstruction leading to ischemia, bacterial overgrowth, and possible perforation .

👉Symptoms
• Classic sequence: vague periumbilical pain → anorexia, nausea, vomiting → pain localizing to the right lower quadrant (RLQ) within 4–48 hours 
• Associated signs: fever, tenderness at McBurney’s point, rebound tenderness, guarding, and leukocytosis.
• Atypical presentations: more common in children, elderly, and pregnant women.

👉Diagnosis
• Primarily clinical, supported by lab and imaging studies.
-Modified Alvarado Score (MASS):
• RLQ tenderness (2), rebound tenderness (1), leukocytosis (2), fever (1), migratory pain (1), nausea/vomiting (1), anorexia (1)
• Score >7 → likely appendicitis; 4–6 → consider CT 
-Imaging:
• CT scan with contrast – sensitivity 91–98%, specificity 95–99%
• Ultrasound – preferred in pregnancy and pediatrics
• MRI – alternative for contrast allergy or renal failure .

👉Differential Diagnosis
• Gastroenteritis
• Mesenteric adenitis
• Meckel’s diverticulitis
• Ovarian torsion / pelvic inflammatory disease
• Renal colic
• Crohn’s disease

👉Treatment

General measures:
• Appendectomy is the standard of care for acute, uncomplicated appendicitis .
• Nonoperative management: antibiotics may be used in select uncomplicated cases, with ~39% recurrence in 5 years .

Antibiotic therapy:
• Uncomplicated: Cefoxitin or ampicillin/sulbactam; or cefazolin + metronidazole
• Nonoperative regimen: Ertapenem (3 days) → oral levofloxacin + metronidazole (7 days)
• Complicated (perforated/gangrenous): Piperacillin-tazobactam or 3rd-gen cephalosporin + metronidazole .

👉Follow-Up
• Discharge once afebrile, tolerating diet, with normal WBC.
• Return to work: 1–2 weeks post uncomplicated appendectomy.
• Activity restriction: avoid heavy lifting for 4–6 weeks.
• If nonoperative and >40 years: colonoscopy to rule out malignancy .

👉Prognosis
• Excellent if treated early.
• Morbidity: 3% (nonperforated), 47% (perforated)
• Mortality:

04/09/2025
02/08/2025

Lowsku wuxuu si gaar ah ugu fiican yahay

1. Lowsku wuxuu si gaar ah ugu fiican yahay kor u qaadista caafimaadka wadnaha, sababtoo ah wuxuu hodan ku yahay dufan caafimaad leh (monounsaturated fats)..

2. Lowsku wuxuu si gaar ah ugu fiican yahay hagaajinta xusuusta iyo shaqada maskaxda, sababtoo ah wuxuu leeyahay fiitamiin E iyo omega-3 fatty acids.

3. Lowsku wuxuu si gaar ah ugu fiican yahay ka hortagga kansarka, maadaama uu leeyahay maadoo lyin sida resveratrol oo caawiya ka hortagga unugyada kansarka.

4. Lowsku wuxuu si gaar ah ugu fiican yahay hagaajinta dheefshiidka, sababtoo ah wuxuu leeyahay fiber badan oo nadiifiya caloosha.

5. Lowsku wuxuu si gaar ah ugu fiican yahay ilaalinta caafimaadka lafaha, sababtoo ah wuxuu leeyahay phosphorus, calcium, iyo magnesium.

6. Lowsku wuxuu si gaar ah ugu fiican yahay hagaajinta aragga, waayo wuxuu ka kooban yahay zinc iyo antioxidants muhiim u ah isha.

7. Lowsku wuxuu si gaar ah ugu fiican yahay korinta timaha, maadaama uu leeyahay biotin iyo borotiin u roon caafimaadka timaha.

8. Lowsku wuxuu si gaar ah ugu fiican yahay xoojinta difaaca jirka, sababtoo ah wuxuu hodan ku yahay fiitamiinada B6, zinc, iyo selenium.

9. Lowsku wuxuu si gaar ah ugu fiican yahay yareynta xanuunada kala goysyada, isagoo leh saliid dabiici ah oo yareysa bararka.

10. Lowsku wuxuu si gaar ah ugu fiican yahay hagaajinta rabitaanka galmada (libido), sababtoo ah wuxuu kor u qaadaa dhiigga soo gaaraya xubinaha taranka

15/05/2025
07/05/2025
09/04/2025

Address

Mogadishu
252

Alerts

Be the first to know and let us send you an email when Dr. Hussein Mohamed Ibrahim posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr. Hussein Mohamed Ibrahim:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram